Thyrotoxicosis clinical trials

The registry lists 21 studies for Thyrotoxicosis across more than 10 countries. 5 are recruiting or about to start. 16 of them are mainly about Thyrotoxicosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-05.

Get an email when these change. Save the Thyrotoxicosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Status unknown: 3
Recruiting: 3
Active, not recruiting: 2
Not yet recruiting: 2

Phase

Phase 4: 1
Phase 3: 1
Phase 2: 1

Where

China: 3
Korea, Republic of: 3
Italy: 2
Taiwan: 1
Greece: 1
Sweden: 1

Who runs them

THYROSCOPE INC. (2) · Seoul National University Bundang Hospital (2) · Ramathibodi Hospital (2) · Zhang Bo (1) · University of Modena and Reggio Emilia (1) · Aristotle University Of Thessaloniki (1) · Universiti Kebangsaan Malaysia Medical Centre (1) · Chinese PLA General Hospital (1)

What is being tested here

Drugs under test in Thyrotoxicosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Lugol's solution	0	1
Thiamine	0	1
Thyroxine	1	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Jun 2027AI-Based Wearable Monitoring (Glandy HYPER) for Antithyroid Drug Dose Adjustment in Graves' Disease · THYROSCOPE INC.

Who these studies take

Of the 3 Thyrotoxicosis studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	1 (33%)	1 (33%)
18	2 (67%)	2 (67%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	3 (100%)	3 (100%)
65	3 (100%)	3 (100%)
75	3 (100%)	3 (100%)
85	2 (67%)	2 (67%)

Across all 21 studies, recruiting or not: 24% stop at 75 or younger and 24% at 65; 29% take children; 5% are for women only and 5% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. search them.